FDA Recalls Ipratropium Bromide Inhalation Solution Due to Manufacturing Deviation
McKesson Medical-Surgical is recalling Ipratropium Bromide Inhalation Solution nationwide due to current good manufacturing practice (cGMP) deviations involving temperature control. The FDA has classified this as a Class II recall.
- Product
- IPRATROPIUM BROMIDE — IPRATROPIUM BROMIDE (IPRATROPIUM BROMIDE)
- Category
- Drug
- Distribution
- Distributed nationwide